...
首页> 外文期刊>Medicine. >Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report
【24h】

Symptomatic pericardial effusion in the setting of asymptomatic COVID-19 infection: A case report

机译:无症状Covid-19感染症状的症状心包积液:案例报告

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Rationale: Infection with the severe acute respiratory coronavirus disease 2019 ( COVID-19 ) has been shown to cause multi-organ involvement including cardiopulmonary serosal layers infection and inflammation. As a result, pericarditis and pericardial effusion may occur with or without COVID-19 related respiratory signs. Due to limitations in sensitivity and specificity of current COVID-19 diagnostic studies, cases that trigger high clinical intuition, even with negative serologic and polymerase chain reaction testing results, may necessitate further diagnostic workup to discover the underlying etiology. Patient concerns: Here we present a rare case of pericardial effusion in the setting of asymptomatic COVID-19 infection manifesting with the chief complaint of chest pain. Diagnosis: While undergoing diagnostic workup, the patients first 2 sets of COVID 19 reverse transcription-polymerase chain reaction (RT-PCR) were negative while a latter RT-PCR test, as well as serology, were positive, leading to the diagnosis of COVID-19 reinfection or subacute presentation of viral infection with pericardial effusion . Echocardiogram depicted large circumferential pericardial effusion with mildly thickened pericardium. Interventions: The patient underwent pericardial window placement followed by ibuprofen administration and discharged from the hospital. Outcomes: During the follow-up visit patient had no symptoms and echocardiogram demonstrated complete resolution of the effusion. Lessons: Due to the possible establishment of pericardial effusions and consecutively tamponade even without any COVID-19 related clinical presentation, it is crucial for clinicians to trust their intuition, conduct the appropriate diagnostic tests, find the underlying diagnosis and prevent the devastating consequences.
机译:理由:患有严重急性呼吸冠状病毒疾病2019(Covid-19)的感染已被证明导致多器官参与,包括心肺血栓层感染和炎症。结果,可以在或没有Covid-19相关呼吸符号发生心包和心包积液。由于目前Covid-19诊断研究的敏感性和特异性的限制,触发高临床直觉的病例,即使具有负血清素和聚合酶链反应测试结果,也可能需要进一步诊断处理以发现潜在的病因。患者涉及:这里我们在表现出胸痛的主要抱怨的无症状Covid-19感染的环境中呈现出罕见的心包积液。诊断:在接受诊断疗效的同时,患者前2套Covid 19逆转录聚合酶链反应(RT-PCR)是阴性的,而后者RT-PCR试验以及血清学均为阳性,导致Covid的诊断-19用心包积液的病毒感染的再感染或亚急性介绍。超声心动图描绘了具有温和加厚的心包的大周向心包。干预措施:患者接受心包窗口的展示位置,然后是布洛芬局给药并从医院排放。结果:在后续访问期间,患者没有症状和超声心动图表明完全分辨率的积分。课程:由于可能在没有任何Covid-19相关的临床介绍的情况下建立心包的潮流和连续填塞,对于临床医生来说,相信他们的直觉是至关重要的,进行适当的诊断测试,找到潜在的诊断并防止破坏性后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号